₹1,267.65
-6.40 (-0.50%)
As of 23 Sept 2026, ERIS Lifesciences Ltd share price is ₹1,267.65. The stock opened at ₹1,267.65 and had closed at ₹1,274.05 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹1,237.90 and a high of ₹1,737.00. In terms of performance, ERIS Lifesciences Ltd share price has decreased by 0.60% over the past six months and has decreased by 21.55% over the last year.
ERIS Stock Price Chart
ERIS Lifesciences Ltd Overview
Market cap₹17,656 Crs
Volume1,061
Prev. Close₹1,274.05
Year range₹1,237.90 - ₹1,737.00
ISININE406M01024
About ERIS
ERIS Lifesciences is engaged in the manufacture and marketing of pharmaceutical products.
ERIS Lifesciences Ltd Historical Performance
1 Month Return-3.88%
6 Month Return0.30%
3 Year Return57.13%
3 Month Return-11.14%
1 Year Return-22.43%
5 Year Return72.94%
ERIS Lifesciences Ltd Fundamentals
ROCE(TTM)10.22%
P/E Ratio (TTM)91.79
P/B Ratio5.53
Debt to Equity0.66
ROE7.64%
EPS (TTM)14.88
Dividend Yield0.57%
Book Value230.58
Profit Margin12.53%
Operating Margin21.29%
ERIS Lifesciences Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 1,920.05 | 1,733.26 | 1,521.54 | 1,347.99 | 1,244.72 |
| EBITDA | 695.97 | 522.06 | 488.65 | 522.38 | 512.99 |
| Net Profit | 244.05 | 77.39 | 299.72 | 398.01 | 417.19 |
| EPS | 17.86 | 5.69 | 22.04 | 29.27 | 30.70 |
ERIS Lifesciences Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 1,257.58 |
| Resistance 1 (R1) | 1,297.43 |
| Pivot Point | 1,280.97 |
ERIS Lifesciences Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 29-May-2026 | 20-May-2026 | 29-May-2026 | Interim | ₹7.21 |
| 13-Feb-2025 | 07-Feb-2025 | 13-Feb-2025 | Interim | ₹7.35 |
| 11-Aug-2022 | 05-Aug-2022 | 16-Aug-2022 | Interim | ₹7.35 |
| 05-Aug-2021 | 29-Jul-2021 | 06-Aug-2021 | Interim | ₹6.01 |
ERIS Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Amit Indubhushan Bakshi | Chairman |
| Kaushal Kamlesh Shah | WTD & Executive Directorector |
| Inderjeet Singh Negi | WTD & Executive Directorector |
ERIS Lifesciences Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,850.20+0.21% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,477.00+1.34% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,921.00-0.28% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of ERIS Lifesciences Ltd today is ₹1,267.65 on NSE and ₹1,267.65 on BSE.
- The 52-week high of ERIS Lifesciences Ltd is ₹1,737.00, while the 52-week low is ₹1,237.90.
- The current market capitalisation of ERIS Lifesciences Ltd is approximately ₹17,656 crore.
- The P/E (Price-to-Earnings) ratio of ERIS Lifesciences Ltd is 39.95. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of ERIS Lifesciences Ltd is 5.35. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy ERIS Lifesciences Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for ERIS on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, ERIS Lifesciences Ltd has delivered a return of approximately 57.13%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of ERIS Lifesciences Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 54.14% promoters, -13.13% FIIs, 20.72% DIIs, and 10.10% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
